Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New gel could replace scraping for leg ulcer cleaning

NCT ID NCT06652360

Symptom relief Sponsor: DEBx Medical B.V. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a chemical gel that dries out wound debris against standard scraping (curettage) for cleaning venous leg ulcers. 80 participants with ulcers at least 6 weeks old were included. The goal was to see which method is safer and more effective at reducing wound size and debris.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Chemical debridement gel (dehydrating agent)
What this could lead to
If successful, this could offer a less painful and more effective way to clean leg ulcers, potentially speeding up healing.
What could go wrong
This is a small pilot study with only 80 participants, so results may not apply to everyone. The chemical gel may not work better than standard curettage, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Nov 2024

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants with a venous leg ulcer or mixed aetiology ulcer. * Duration of wound ≥ 6 weeks ≤ 5 years * Wound is ≥ 5 cm2 ≤ 200cm2 * Presence of at least 25% visible slough within the wound bed * The Participant must be able to understand the study and provide written informed consent * No clinical signs of infection Exclusion Criteria: * Known hypersensitivity or contraindications to any of the wound treatments, dressings or compression bandaging to be used in the trial * Current local or systemic antibiotics in the week prior to inclusion * Clinically infected wound as determined by the presence of 3 or more of the following clinical signs: perilesional erythema, pain between two dressing changes, malodorous wound, abundant exudate and oedema * Prolonged treatment with immunosuppressive agents or high dose corticosteroids * Participants who have a current illness or condition which may interfere with wound healing in the last 30 days (carcinoma, connective tissue disease, autoimmune disease or alcohol or drug abuse) * Participants who have participated in a clinical trial on wound healing within the past month * Participants with a known history of non- adherence with medical treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mixed ulcer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mixed ulcer Venous leg ulcers

Contacts and locations

Locations

  • Pioneer wound healing and lymphedema centres

    Eastbourne, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.